BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 19713938)

  • 1. Modulation of intracellular ROS levels by TIGAR controls autophagy.
    Bensaad K; Cheung EC; Vousden KH
    EMBO J; 2009 Oct; 28(19):3015-26. PubMed ID: 19713938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIGAR, a p53-inducible regulator of glycolysis and apoptosis.
    Bensaad K; Tsuruta A; Selak MA; Vidal MN; Nakano K; Bartrons R; Gottlieb E; Vousden KH
    Cell; 2006 Jul; 126(1):107-20. PubMed ID: 16839880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death.
    Cheung EC; Ludwig RL; Vousden KH
    Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20491-6. PubMed ID: 23185017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis.
    Wanka C; Steinbach JP; Rieger J
    J Biol Chem; 2012 Sep; 287(40):33436-46. PubMed ID: 22887998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATM-NFκB axis-driven TIGAR regulates sensitivity of glioma cells to radiomimetics in the presence of TNFα.
    Sinha S; Ghildiyal R; Mehta VS; Sen E
    Cell Death Dis; 2013 May; 4(5):e615. PubMed ID: 23640457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 induced glycolysis and apoptosis regulator (TIGAR) knockdown results in radiosensitization of glioma cells.
    Peña-Rico MA; Calvo-Vidal MN; Villalonga-Planells R; Martínez-Soler F; Giménez-Bonafé P; Navarro-Sabaté À; Tortosa A; Bartrons R; Manzano A
    Radiother Oncol; 2011 Oct; 101(1):132-9. PubMed ID: 21864926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer.
    Ko YH; Domingo-Vidal M; Roche M; Lin Z; Whitaker-Menezes D; Seifert E; Capparelli C; Tuluc M; Birbe RC; Tassone P; Curry JM; Navarro-Sabaté À; Manzano A; Bartrons R; Caro J; Martinez-Outschoorn U
    J Biol Chem; 2016 Dec; 291(51):26291-26303. PubMed ID: 27803158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the MUC1-C oncoprotein induces multiple myeloma cell death by down-regulating TIGAR expression and depleting NADPH.
    Yin L; Kosugi M; Kufe D
    Blood; 2012 Jan; 119(3):810-6. PubMed ID: 22117045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure, regulation, and biological functions of TIGAR and its role in diseases.
    Tang J; Chen L; Qin ZH; Sheng R
    Acta Pharmacol Sin; 2021 Oct; 42(10):1547-1555. PubMed ID: 33510458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of TIGAR by RNA interference induces apoptosis and autophagy in HepG2 hepatocellular carcinoma cells.
    Ye L; Zhao X; Lu J; Qian G; Zheng JC; Ge S
    Biochem Biophys Res Commun; 2013 Jul; 437(2):300-6. PubMed ID: 23817040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIGAR induces p53-mediated cell-cycle arrest by regulation of RB-E2F1 complex.
    Madan E; Gogna R; Kuppusamy P; Bhatt M; Pati U; Mahdi AA
    Br J Cancer; 2012 Jul; 107(3):516-26. PubMed ID: 22782351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIGAR impedes compression-induced intervertebral disc degeneration by suppressing nucleus pulposus cell apoptosis and autophagy.
    Li Z; Shao Z; Chen S; Huang D; Peng Y; Chen S; Ma K
    J Cell Physiol; 2020 Feb; 235(2):1780-1794. PubMed ID: 31317559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Is Upregulated in Lymphocytes Stimulated with Concanavalin A.
    Simon-Molas H; Vallvé-Martínez X; Caldera-Quevedo I; Fontova P; Arnedo-Pac C; Vidal-Alabró A; Castaño E; Navarro-Sabaté À; Lloberas N; Bartrons R; Manzano A
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic role of the TP53-induced glycolysis and apoptosis regulator in nasopharyngeal carcinoma through NF-κB pathway modulation.
    Zhao M; Fan J; Liu Y; Yu Y; Xu J; Wen Q; Zhang J; Fu S; Wang B; Xiang L; Feng J; Wu J; Yang L
    Int J Oncol; 2016 Feb; 48(2):756-64. PubMed ID: 26691054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIGAR overexpression diminishes radiosensitivity of parotid gland fibroblast cells and inhibits IR-induced cell autophagy.
    Tai G; Zhang H; Du J; Chen G; Huang J; Yu J; Cai J; Liu F
    Int J Clin Exp Pathol; 2015; 8(5):4823-9. PubMed ID: 26191173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human T-cell leukemia virus type-1 p30
    Romeo M; Hutchison T; Malu A; White A; Kim J; Gardner R; Smith K; Nelson K; Bergeson R; McKee R; Harrod C; Ratner L; Lüscher B; Martinez E; Harrod R
    Virology; 2018 May; 518():103-115. PubMed ID: 29462755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of TIGAR sensitizes the antitumor effect of physapubenolide through increasing intracellular ROS levels to trigger apoptosis and autophagosome formation in human breast carcinoma cells.
    Ma T; Zhang Y; Zhang C; Luo JG; Kong LY
    Biochem Pharmacol; 2017 Nov; 143():90-106. PubMed ID: 28774732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting MUC1-C is synergistic with bortezomib in downregulating TIGAR and inducing ROS-mediated myeloma cell death.
    Yin L; Kufe T; Avigan D; Kufe D
    Blood; 2014 May; 123(19):2997-3006. PubMed ID: 24632713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of TP53-induced glycolysis and apoptosis regulator on malignant activity and resistance to ferroptosis in intrahepatic cholangiocarcinoma.
    Toshida K; Itoh S; Iseda N; Izumi T; Yoshiya S; Toshima T; Ninomiya M; Iwasaki T; Oda Y; Yoshizumi T
    Cancer Sci; 2024 Jan; 115(1):170-183. PubMed ID: 37878531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decitabine Downregulates TIGAR to Induce Apoptosis and Autophagy in Myeloid Leukemia Cells.
    Li L; Liu W; Sun Q; Zhu H; Hong M; Qian S
    Oxid Med Cell Longev; 2021; 2021():8877460. PubMed ID: 33532040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.